Title : Transient activation of EGFR/AKT cell survival pathway and expression of survivin contribute to reduced sensitivity of human melanoma cells to betulinic acid.

Pub. Date : 2005 Sep

PMID : 16077934






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Transient activation of EGFR/AKT cell survival pathway and expression of survivin contribute to reduced sensitivity of human melanoma cells to betulinic acid. betulinic acid AKT serine/threonine kinase 1 Homo sapiens
2 Further, BA strongly induced AKT phosphorylation in a similar pattern. betulinic acid AKT serine/threonine kinase 1 Homo sapiens
3 AKT activation started 15 min post-treatment, peaked at approximately 1 h, remained elevated for 4 h and returned to basal level within 8 h. BA also induced ERK activation and, in contrast, weakly induced JNK and p38 activation. betulinic acid AKT serine/threonine kinase 1 Homo sapiens
4 Pretreatment of EGFR inhibitor PD153035 blocked BA-induced EGFR phosphorylation, ERK and AKT activation, and survivin expression. betulinic acid AKT serine/threonine kinase 1 Homo sapiens
5 Collectively, we conclude that betulinic acid transiently activated the EGFR/AKT cell survival pathway and induced survivin expression, contributing to less sensitivity in human melanoma cells. betulinic acid AKT serine/threonine kinase 1 Homo sapiens